PRKD1 and prostate cancer: Given the effects of PKD3 knockdown by siRNA or CID755673 in the inhibition of prostate cancer cell proliferation [18,20] and the implications that PKD regulates cell survival and proliferation [12,29], we wanted to test whether the new compounds were cytotoxic and whether they also inhibited prostate cancer cell proliferation.